Facility Information

GUAYAQUIL, ECUADOR
WORLDWIDE MEDICINES

Facts and Figures

The Bristol-Myers Squibb Ecuador facility produces pharmaceutical and consumer medicines and nutritionals for both domestic and international markets. Dosage forms include solids, oral liquids, semisolids, injectables, and powders for injection. Product types manufactured include:

Anti-infectives
Infant formulas
Vitamin products
Analgesics

Both pharmaceutical and nutritional products are exported to Andean Pact Countries and Central America.

Economic Development

A laboratory for cephalosporin products was constructed in the cephalosporin manufacturing building to improve product separation and prevent cross-contamination.

Community and Social Progress

The laboratory expansion includes a 100 percent fresh air feature to minimize employees' exposure to chemicals.

Environmental Performance

A new waste water treatment plant has been installed with a capacity to manage semisolids oil-based manufacturing.
Facility personnel use a contractor for recycling cardboard, paper, and disposal of lab solvents.

Facility Contact Information

+593-4211-0585

Last updated October 27, 2006 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Facility Information:

Facts and Figures

Economic Development

Community and Social Progress

Environmental Performance

Facility Contact Information

Return to List of Facilities